Revance Therapeutics Inc (RVNC)

[DewDiligence]

I think you're splitting hairs. The Cosmo author says, "you should expect to pay 50 to 100 percent more for Daxxify than other neuromodulators...because you’ll need close to double the units..." That's essentially the double-dose canard. Most readers will likely interpret the above to mean that Daxxify is a high-dose option.